These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 17318076

  • 21. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 22. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Gotoh K, Ito Y, Ohta R, Iwata S, Nishiyama Y, Nakamura T, Kaneko K, Kiuchi T, Ando H, Kimura H.
    J Infect Dis; 2010 Aug 15; 202(3):461-9. PubMed ID: 20560768
    [Abstract] [Full Text] [Related]

  • 23. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar 15; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 24. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
    Schaffer K, Hassan J, Staines A, Coughlan S, Holder P, Tuite G, McCormick AP, Traynor O, Hall WW, Connell J.
    Liver Transpl; 2011 Dec 15; 17(12):1420-6. PubMed ID: 21837744
    [Abstract] [Full Text] [Related]

  • 25. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Dec 15; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 26. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 15; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 27. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 28. Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
    Rosselet A, Vu DH, Meylan P, Chaubert AS, Schapira M, Pascual M, Aubert V, Tissot JD, Duchosal MA.
    Clin Transplant; 2009 Feb 15; 23(1):74-82. PubMed ID: 19200218
    [Abstract] [Full Text] [Related]

  • 29. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 30. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct 15; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

  • 31. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H.
    Transpl Int; 2002 Nov 15; 15(11):529-34. PubMed ID: 12461655
    [Abstract] [Full Text] [Related]

  • 32. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J, Einsele H, Gil L, Ljungman P.
    Transpl Infect Dis; 2009 Oct 15; 11(5):383-92. PubMed ID: 19558376
    [Abstract] [Full Text] [Related]

  • 33. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 34. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L, Linde A, Falk KI.
    Transpl Int; 2005 Jul 15; 18(7):835-43. PubMed ID: 15948864
    [Abstract] [Full Text] [Related]

  • 35. Epstein-Barr viral infection in renal allograft recipients: a single center experience.
    Zadeh ZR, Makhdumi K, Lak SS.
    Saudi J Kidney Dis Transpl; 2006 Sep 15; 17(3):351-4. PubMed ID: 16970255
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E, Cornelissen JJ.
    Curr Opin Hematol; 2008 Nov 15; 15(6):576-85. PubMed ID: 18832928
    [Abstract] [Full Text] [Related]

  • 37. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 38. Molecular epidemiology of Epstein-Barr virus in adult kidney transplant recipients.
    Cavallo R, Elia M, Gruosso V, Curtoni A, Costa C, Bergallo M.
    Transplant Proc; 2010 Sep 15; 42(7):2527-30. PubMed ID: 20832536
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 40. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
    Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG.
    Pediatr Transplant; 2008 Jun 27; 12(4):464-8. PubMed ID: 18466434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.